Table 2.
Adverse Occurrence | n | Association with mortality | ||
---|---|---|---|---|
RR | 95%CI | p | ||
ARDS | 59 | 10.40 | (7.23– 14.94) | 0.00 |
Acute Respiratory Failure | 240 | 4.39 | (3.16– 6.1) | 0.00 |
Apiration Pneumonia | 205 | 3.86 | (2.67– 5.59) | 0.00 |
Atelectasis | 154 | 2.94 | (1.83– 4.75) | 0.00 |
Pneumonia | 422 | 3.01 | (2.2– 4.11) | 0.00 |
Pneumothorax | 30 | 3.68 | (1.47– 9.23) | 0.02 |
Pulmonary Embolism | 57 | 2.91 | (1.36– 6.27) | 0.02 |
Extremity Compartment Syndrome | 46 | 1.79 | (.6– 5.38) | 0.24 |
Deep Venous Thrombosis | 289 | 1.54 | (.94– 2.52) | 0.11 |
Arrhythmia | 149 | 7.62 | (5.62– 10.33) | 0.00 |
Transfusion Reaction | 3 | 9.13 | (1.84– 45.43) | 0.11 |
Coagulopathy | 95 | 13.55 | (10.44– 17.58) | 0.00 |
Pleural Effusion | 64 | 2.59 | (1.2– 5.6) | 0.03 |
Hypothermia | 5 | 16.55 | (8.02– 34.15) | 0.00 |
Post-operative Haemorrhage | 23 | 4.80 | (1.96– 11.79) | 0.01 |
Cardiopulmonary Arrest | 79 | 16.79 | (13.2– 21.34) | 0.00 |
Acute Kidney Injury | 74 | 13.60 | (10.27– 18.01) | 0.00 |
Hepatic Failure | 5 | 16.55 | (8.02– 34.15) | 0.00 |
Dehiscence | 35 | 1.56 | (.41– 6.04) | 0.37 |
Stroke | 37 | 2.98 | (1.17– 7.57) | 0.05 |
Empyema | 14 | 3.92 | (1.08– 14.22) | 0.09 |
Sepsis | 63 | 11.76 | (8.48– 16.3) | 0.00 |
Septicemia | 116 | 3.67 | (2.26– 5.97) | 0.00 |
Gastrointestinal Bleed | 52 | 5.40 | (3.06– 9.54) | 0.00 |
Organ, Vessel, Nerve Damage | 51 | 2.71 | (1.17– 6.27) | 0.04 |
Decubitus | 138 | 1.81 | (.95– 3.43) | 0.10 |
Urinary Tract Infection | 323 | 1.46 | (.91– 2.36) | 0.13 |
Wound Infection | 149 | 1.86 | (1.01– 3.43) | 0.07 |
RR= Relative Risk, CI = Confidence Interval, ARDS=Acute Respiratory Distress Syndrome. P values for Fisher’s exact test.